Xolytix

Xolytix is an early-stage healthcare technology company developing an integrated point-of-care platform for exosome characterization. The company is focused on using exosome-based analysis for early disease detection and for assessing treatment response, with oncology appearing to be an important early application area. Publicly available information suggests Xolytix is a very early company that has participated in a Texas-based cancer therapeutics accelerator and has received incubator/accelerator backing. The company appears to be private and active, but there is limited public disclosure on named product candidates, clinical programs, or commercial operations.